article thumbnail

What Could Rescheduling Mean for Medical Cannabis Patients?

Canna Care Docs

Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. Understanding current drug scheduling for cannabis The DEA classifies drugs, substances, and certain chemicals used to make drugs into five distinct categories or “schedules.”

Patients 111
article thumbnail

One Signature Could Remove Marijuana From Schedule I Tomorrow

Canna Law Blog

Yes, the DEA would need to do some light follow-up rulemaking—but that’s been done before , and the Office of Legal Counsel has already signed off on it. In fact, even if marijuana gets rescheduled via the full DEA/HHS process and lands in Schedule III, a future AG could use § 811(d)(1) to shove it right back into Schedule I.

Marijuana 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Intoxicating Hemp Swindle

Project CBD

In response to its growing popularity, the DEA announced in 2016 that kratom would be placed in the restrictive Schedule I along with cannabis. However, the following year the DEA put off its decision pending further public commentary. Yet its advocates tout its ability to help wean users off opioids.

Hemp 233
article thumbnail

Lunch & Learn Episode 6: Is Cannabis' "Accepted Medical Use" Political?

Americans for Safe Access

While Schedule III may seem like a large deviation from the recommendations provided by HHS and DEA in 2016, outright dismissing the finding of HHS and DOJ, currently accepted medical use does not take into account the enormity of the scientific and medical discoveries that have happened in the time since they were issued as well as the vast societal (..)

DEA 130
article thumbnail

America’s Missed Opportunity in the Global Marijuana Market

Canna Law Blog

As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. And even within that narrow scope, access is tightly limited: only eight DEA-registered bulk manufacturers are allowed to participate. In contrast, the U.S. marijuana policy permits only marijuana for research purposes.

DEA 113
article thumbnail

Locked Out: SBA’s New Lending Policy Targets Hemp and Marijuana-Adjacent Businesses

Canna Law Blog

Further, other federal agencies may see that neither DEA nor FDA need to enforce federal law to shut down the Consumable Hemp Product industry. Unlike well-funded operators with access to private capital, they depend on SBA programs to survive and grow. With this new policy, compliance confusion becomes a death sentence.

Policy 56
article thumbnail

The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers

Canna Law Blog

But there’s a group of players who’ve been surprisingly quiet, despite potentially having the most to gain: DEA-registered bulk marijuana manufacturers. However, under current US law, DEA Registrants are missing out on a massive opportunity. This booming global market is one that DEA Registrants are unable to access.

DEA 69